|
US2013130998A1
|
|
Analogues of etoposide for the treatment of tumours
|
|
WO2006077152A2
|
|
Hla fusion molecules and uses thereof
|
|
EP1701739A2
|
|
Use of agents derived from ceacam1 for the treatment of inflammatory diseases
|
|
US2005221424A1
|
|
Bispecific molecules for use in therapy and diagnosis of immune related and other diseases
|
|
EP1492555A2
|
|
Compositions and methods for modulation of effects on phagocyte and lymphoid cell population
|
|
EP1430084A2
|
|
Peptides capable of modulating immune response
|
|
WO2004011496A2
|
|
Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
|
|
WO0236149A2
|
|
Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
|
|
EP1297011A1
|
|
Diagnostic uses of the t-cell protein tzon7, and of the peptides and antibodies derived therefrom
|
|
AU2153901A
|
|
Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof
|
